Prism Medico & PharmacyBOM:512217 53 Piotroski F-Score is 8 as of Jul. 11, 2026, which is 33% above its 10-year median of 6.00. GuruFocus rates BOM:512217 with a GF Score™ of 53/100 and a GF Value™ of ₹27.40 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,911 Consumer Packaged Goods companies, Prism Medico & Pharmacy ranks better than 97.65% on this metric.
Good Sign:
Piotroski F-Score is 8, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Prism Medico & Pharmacy has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Prism Medico & Pharmacy's Piotroski F-Score or its related term are showing as below:
BOM:512217'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 6 Max: 8
Current: 8
During the past 13 years, the highest Piotroski F-Score of Prism Medico & Pharmacy was 8. The lowest was 2. And the median was 6.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Prism Medico & Pharmacy Piotroski F-Score Related Terms
Prism Medico & Pharmacy Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Prism Medico & Pharmacy's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:512217 vs ADM, BG, TSN: Piotroski F-Score Comparison
For the Farm Products subindustry, Prism Medico & Pharmacy's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prism Medico & Pharmacy Piotroski F-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Prism Medico & Pharmacy's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Prism Medico & Pharmacy's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Prism Medico & Pharmacy's current Net Income (TTM) was 3.18.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Prism Medico & Pharmacy's current Cash Flow from Operations (TTM) was 0.02.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Prism Medico & Pharmacy's return on assets of this year was 0.02045681. Prism Medico & Pharmacy's return on assets of last year was -0.00319489.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Prism Medico & Pharmacy's gearing of this year was 0. Prism Medico & Pharmacy's gearing of last year was 0.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Prism Medico & Pharmacy's current ratio of this year was 77.33616808. Prism Medico & Pharmacy's current ratio of last year was 32.43226627.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Prism Medico & Pharmacy's number of shares in issue this year was 6.063. Prism Medico & Pharmacy's number of shares in issue last year was 6.063.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Prism Medico & Pharmacy's gross margin of this year was 0.35794385. Prism Medico & Pharmacy's gross margin of last year was 0.2902358.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Prism Medico & Pharmacy's asset turnover of this year was 0.15698545. Prism Medico & Pharmacy's asset turnover of last year was 0.04145482.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
0
+
1
+
1
+
1
+
1
+
1
=
8
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Prism Medico & Pharmacy has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.
Prism Medico & Pharmacy (BOM:512217) has a Piotroski F-Score of 8 as of Jul. 11, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Prism Medico & Pharmacy and its competitors. This is 33% above median its historical median of 6.00. Over the past decade, Prism Medico & Pharmacy's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Prism Medico & Pharmacy ranks #45 out of 1911 companies in the Consumer Packaged Goods industry, placing it in the top 2.4%.
Is Prism Medico & Pharmacy's Piotroski F-Score too high?
Prism Medico & Pharmacy's current Piotroski F-Score of 8 is 33% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Prism Medico & Pharmacy's value of 8 is 60% above this industry median. Based on the distribution chart, Prism Medico & Pharmacy ranks #45 out of 1911 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Prism Medico & Pharmacy has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Prism Medico & Pharmacy's Piotroski F-Score compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Prism Medico & Pharmacy ranks #45 out of 1911 companies for Piotroski F-Score. This places Prism Medico & Pharmacy in the top 2% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Prism Medico & Pharmacy's value of 8 is 60% above this benchmark. Historically, Prism Medico & Pharmacy's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Prism Medico & Pharmacy has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,911 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prism Medico & Pharmacy's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Prism Medico & Pharmacy and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prism Medico & Pharmacy's current Piotroski F-Score is 8, which is 33% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Medico & Pharmacy stock overvalued right now?
Based on GuruFocus' analysis, Prism Medico & Pharmacy (BOM:512217) is currently considered Fairly Valued. The stock's GF Value™ is ₹27.40, compared to a current price of ₹28.80 — trading 5.1% above its estimated fair value. The current Piotroski F-Score is 8, which is 33% above median its 10-year median of 6.00 and 60% above the Consumer Packaged Goods industry median of 5.00. Prism Medico & Pharmacy's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Prism Medico & Pharmacy (BOM:512217), the current Piotroski F-Score is 8 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prism Medico & Pharmacy (BOM:512217) Overvalued in 2026?
Based on GuruFocus' analysis, Prism Medico & Pharmacy stock appears to be overvalued.
The current stock price of ₹28.80 is trading 5.1% above its estimated GF Value™ of ₹27.40.
GuruFocus considers Prism Medico & Pharmacy to be Fairly Valued.
Key valuation signals for BOM:512217:
Piotroski F-Score: 8 (33% above median its 10-year median of 6.00)
GF Value™: ₹27.40 vs. price of ₹28.80 (5.1% above fair value)
Industry Position: 60% above the Consumer Packaged Goods median (#45 of 1911)
No single metric tells the full story. See the BOM:512217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prism Medico & Pharmacy Ltd operates in the wholesale and retail of animal feed, poultry feed, cattle feed, aqua feed, ayurvedic foods, organic food, juices, cosmetics, herbal extracts, nutrients, and FMCG products. The company generates the majority of its revenue from the sale of agricultural products.
53GF Score
Get the complete analysis for BOM:512217
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512217 has been successfully added to your 
